Published in Cancer on March 15, 1985
Management of metastatic melanoma during pregnancy. BMJ (1998) 2.10
A proposal for the timing of management of patients with melanoma presenting during pregnancy. J Surg Oncol (2012) 1.40
Cancer in pregnancy: maternal-fetal conflict. J Cancer Res Clin Oncol (2003) 1.08
Malignant melanoma arising during pregnancy. A study of 100 patients. Ann Surg (1990) 1.03
Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol (2009) 1.00
Malignant melanoma and pregnancy ten questions. West J Med (1996) 0.85
Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis. Am J Pathol (2011) 0.82
Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men. Am J Dermatopathol (2014) 0.80
Pregnancy is Not Detrimental to the Melanoma Patient with Clinically Localized Disease. J Clin Aesthet Dermatol (2010) 0.78
Risk factors for intraocular melanoma and occupational exposure. Br J Ophthalmol (1999) 0.78
Melanoma in pregnancy: a case report and review of the literature. Postepy Dermatol Alergol (2015) 0.76
Cutaneous Melanoma in Women. Int J Womens Dermatol (2015) 0.76
The influence of pregnancy on the recurrence of cutaneous malignant melanoma in women. Dermatol Res Pract (2010) 0.76
A word of caution: do not wake sleeping dogs; micrometastases of melanoma suddenly grew after progesterone treatment. BMC Cancer (2013) 0.75
Malignant melanoma in pregnancy. Ulster Med J (1987) 0.75
Estrogen Receptor Alpha (ESR1) Single-Nucleotide Polymorphisms (SNPs) Affect Malignant Melanoma Susceptibility and Disease Course. Genet Epigenet (2016) 0.75
Cutaneous melanoma in women. Int J Womens Dermatol (2017) 0.75
Prognosis for women diagnosed with melanoma during, before, or after pregnancy: Weighing the evidence. Int J Womens Dermatol (2017) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med (1985) 5.82
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA (1996) 4.13
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg (1998) 3.11
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
Actinomycin D: inhibition of respiration and glycolysis. Science (1966) 2.47
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res (1986) 2.37
Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol (1999) 2.36
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. J Immunol (1989) 2.32
Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg (1990) 2.27
Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer (1998) 2.11
The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol (1988) 2.06
Improved computer program data for the resolution and fractionation of macromolecules by isokinetic sucrose density gradient sedimentation. Anal Biochem (1974) 2.06
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg (1999) 2.02
Resolution and fractionation of macromolecules by isokinetic sucrose density gradient sedimentation. Anal Biochem (1968) 2.02
Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res (1986) 2.01
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods. Cancer Res (1989) 2.00
Hydroporation as the mechanism of hydrodynamic delivery. Gene Ther (2004) 1.97
In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol Surg (2000) 1.95
Metastatic melanoma in the thorax: report of 130 patients. AJR Am J Roentgenol (1981) 1.95
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg (1995) 1.90
Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab (1988) 1.78
Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery (1990) 1.72
Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol (1999) 1.68
Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am (1998) 1.67
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol (2001) 1.66
Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol (1998) 1.64
Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA (1998) 1.62
Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg (1991) 1.61
Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial. J Infect Dis (1997) 1.60
MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J Immunol (1991) 1.60
Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract. Surgery (1984) 1.59
Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. Arch Surg (1994) 1.56
Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. Ann Surg (1988) 1.55
Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med (1998) 1.54
Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer (1998) 1.54
Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer (1999) 1.54
The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg (2001) 1.53
Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol (1999) 1.50
The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med (1997) 1.50
The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol (1981) 1.49
Influence of physician communication on newly diagnosed breast patients' psychologic adjustment and decision-making. Cancer (1994) 1.46
Frequent microsatellite instability in primary small cell lung cancer. Cancer Res (1994) 1.44
Serological prevalence study of exposure of cats and dogs in Launceston, Tasmania, Australia to spotted fever group rickettsiae. Aust Vet J (2010) 1.43
Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol (1994) 1.43
Pulmonary lymphangiomyomatosis responsive to progesterone. N Engl J Med (1980) 1.43
Analysis of residual cancer after diagnostic breast biopsy: an argument for fine-needle aspiration cytology. Ann Surg Oncol (1995) 1.42
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg (1994) 1.41
Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia (1979) 1.41
Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer (1996) 1.41
Randomized trial of high-dose chemotherapy with autologous bone marrow support as adjuvant therapy for high-risk, multi-node-positive malignant melanoma. J Natl Cancer Inst (1993) 1.40
Toxic shock syndrome after a human bite to the hand. J Hand Surg Am (1988) 1.39
Lymphatic mapping and sentinel node biopsy in the management of high-risk melanoma. J Am Acad Dermatol (1998) 1.38
Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res (1994) 1.38
Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol (2000) 1.38
Chloroma (granulocytic sarcoma) without evidence of leukemia: facilitated light microscopic diagnosis. Blood (1980) 1.37
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Lethal "thin" malignant melanoma. Identifying patients at risk. Ann Surg (1988) 1.30
Skin graft rejection between subjects genotyped for HL-A. Transplant Proc (1969) 1.29
Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg (1992) 1.28
Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg (2001) 1.28
Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery (1998) 1.28
Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg (1991) 1.27
The complex repeats of Dictyostelium discoideum. Genome Res (2001) 1.27
Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg (1983) 1.26
Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery (2001) 1.26
Positron emission tomography scanning in malignant melanoma. Cancer (2000) 1.25
Context effects and the (mal)adaptive nature of guilt and shame in children. Genet Soc Gen Psychol Monogr (2000) 1.24
Thymolipoma in association with myasthenia gravis. Arch Pathol Lab Med (1978) 1.24
Infertile or childless by choice? A multipractice survey of women aged 35 and 50. Br Med J (Clin Res Ed) (1987) 1.23
Central nervous system metastases in malignant melanoma. Neurosurgery (1981) 1.21
Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal. J Natl Cancer Inst (1977) 1.18
Selection of patients for heterotopic implantation of the areola and nipple. Surg Gynecol Obstet (1980) 1.17
Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery (1993) 1.16
Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann Surg (2001) 1.15
Anomalous MLR responsiveness among siblings. Transplant Proc (1971) 1.15
Hepatobiliary cystadenoma with mesenchymal stroma. Ann Surg (1990) 1.14
The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg (1999) 1.14
Recurrent malignant melanoma: the identification of prognostic factors to predict survival. Ann Plast Surg (1992) 1.13
Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol (1984) 1.13
Characterization of 5.8-S RNA from a complex with 26-S ribosomal RNA from Arbacia punctulata. Biochim Biophys Acta (1970) 1.12
Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol (1997) 1.12
Screening of pigs resistant to F4 enterotoxigenic Escherichia coli (ETEC) infection. Vet Microbiol (2007) 1.11
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
Evidence for a proposed initiation complex for protein synthesis in reticulocyte polyribosome profiles. Proc Natl Acad Sci U S A (1969) 1.10
Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy. Ann Surg (1989) 1.10